How many insider trades does FilingIQ track for TELO?

FilingIQ tracks 4 Form 4 insider transactions for TELO (Telomir Pharmaceuticals, Inc.), covering filings from Feb 13, 2024 onwards. 1 of those were filed in the last 90 days.

Are TELO insiders net buyers or net sellers?

Across the full Form 4 history for TELO, 3 transactions (75%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TELO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TELO in?

Telomir Pharmaceuticals, Inc. (TELO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $48.13M.

TELO insider trading

NasdaqCM Healthcare

Telomir Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

75% / 0%

Market cap

$48.13M

About Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Company website: telomirpharma.com

TELO insider activity at a glance

FilingIQ has scored 4 insider transactions for TELO since Feb 13, 2024. The most recent filing in our index is dated Apr 22, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TELO insider trades is 47.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TELO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TELO?: FilingIQ tracks 4 Form 4 insider transactions for TELO (Telomir Pharmaceuticals, Inc.), covering filings from Feb 13, 2024 onwards. 1 of those were filed in the last 90 days.
Are TELO insiders net buyers or net sellers?: Across the full Form 4 history for TELO, 3 transactions (75%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TELO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TELO in?: Telomir Pharmaceuticals, Inc. (TELO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $48.13M.

Methodology & sources

Every TELO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.